 ScreeningInformed Consent: Sixteen subjects will be recruited for the clinical protocol. All protocols, consent forms, and HIPAA forms shall be IRB-approved prior to initiating any study procedure or recruitment. At a screeninginformed consent visit, the study design, purposes and inclusionexclusion criteria will be explained to each prospective subject. Written informed consent will be obtained prior to commencing any study procedures. After informed consent is obtained, medical examinations will be performed along with baseline serum chemistries, complete blood count, electrocardiogram, urinalysis, urine drug screen, nicotinecotinine, and urine pregnancy test females. Subjects will be asked about their diets including alcohol use and the use of herbal medicationsdietary supplements. If a potential subject has been consuming any herbal or dietary supplements a two-week period of abstinence from supplement use will be necessary before beginning the study. Additionally, subjects will refrain from use of honey or propolis-containing products due to presence of chrysin and potential assay interference, and artichokes, or artichoke-containing foods that also contain taxifolin a constituent found in MT. 